Terry Simons

Currently enrolling: Pneumonia Pathogen Analysis Study to obtain respiratory samples from dogs & cats diagnosed w/pneumonia & already scheduled to have respiratory samples collected as part of their diagnostic workup. Learn more at ethosdiscovery.org. #ethosdiscovery

Today we recognize & thank all veterinary professionals whose hard work saves lives & powers us to pursue scientific veterinary innovations in Oncology, Emergency & Critical Care, Gastroenterology, Neurology, Innovations in Surgery & Therapeutics. ethosdiscovery.org. #vetmed

#EthosDiscovery is committed to improving both veterinary & human patients care. We provide data generated by our clinical work to organizations conducting similar research in the human medical field, so they can benefit people w/conditions similar to those that affect pets.

After losing her adopted rescue, Mackie to a neurological condition, Stephanie heard about the #EthosDiscovery inflammatory CNS disease study for pug NME clinical trial at Wheat Ridge Animal Hospital. She brought her other pug companion, Mark to participate. #vetmed 📸Mackie

We regularly update the current status of our clinical trials on our website. Each study features a contact form that you can use to reach us if your pet is eligible for enrollment, or to get more information about the studies that we are currently conducting. #ethosdiscovery

Enrolling your pet in a clinical trial may not only benefit your pet but others as well. Many studies allow your pet to receive treatment or diagnostic procedures that wouldn't otherwise be available to them, while the data collected from other studies benefit future patients.

Cannabidiol (CBD) is the most promising phytocannabinoid, due to its non-psychotropic effects, low toxicity, & high tolerability. Ethos Discovery has upcoming novel therapeutics studies for using CBD to treat various diseases in canines. #ethosdiscovery #cbd #vetmed

Similarity of disorders in pets & humans is widely recognized. It's likely innovations we're working on will help future human patients. Our efforts began in oncology & have expanded to deliver innovations to all fields of #vetmed & surgery #ethosdiscovery

Hemangiosarcoma (HSA) is an aggressive cancer in dogs with a poor prognosis. Our previous HSA work, the Canine HSA Molecular Profiling study, provides new knowledge for innovative trials investigating HSA diagnosis, prognosis, & treatment. #ethosdiscovery #vetmed

Dr. Chand Khanna's role as President of Ethos Discovery (a 501c3 incubator of scientific innovation) allows him to help develop scientific innovations for both human & veterinary patients with complex medical problems. #vetmed #ethosdiscovery